19:50 IST
BSE
Business UpdatePiramal Pharma Ltd PPLPHARMA
Piramal Pharma Business Update
Piramal Pharma reported that the US FDA issued a Form-483 with 7 observations following a GMP inspection of its Morpeth, UK facility.
ALFA Filings
Every announcement, straight from the exchange
Every Piramal Pharma business update announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Piramal Pharma reported that the US FDA issued a Form-483 with 7 observations following a GMP inspection of its Morpeth, UK facility.
Piramal Pharma Limited released its Sustainability Report for FY2025-26, detailing the company's ESG performance across key pillars, including business resilience and operational sustainability.
Piramal Pharma has resumed operations at its Ahmedabad facility following the recent temporary suspension due to heavy rainfall. Operations are substantially restored with no material financial impact.